Investor Relations

Conversion Labs is a rapidly growing direct to consumer telemedicine and wellness company. In addition to our proven online marketing expertise, we have built a technology platform, online pharmacy infrastructure and nationwide physician network to treat patients, prescribe prescription medications, and ship prescription and over the counter medications directly to patients in all 50 states. We believe telemedicine will transform the American healthcare system by increasing access to care and improving outcomes. We’re proud to be a leader in this rapidly evolving space.

Investor Documents

Investor Presentation

See our latest corporate presentation.

View
'20 Letter to Shareholders

See our latest shareholder letter.

View
2019 Annual Filing

See our latest annual filing.

View

Latest News

{{ news.pubDate }}

{{ `${news.title}` }}

Read More

Receive automated Investor Alerts directly to your inbox

Stock Information

SEC Filings

{{ `${sec.title}` }}

{{ sec.description }}

Frequently Asked Questions

Our stock is traded on the OTCQB under the symbol CVLB.
Conversion Labs is incorporated in the State of Delaware in the U.S.
800 Third Avenue
Suite 2800
New York, New York
The last day of our fiscal year is December 31. Our fiscal quarters end on March 31, June 30, September 30, and December 31.
Worldwide Stock Transfer
1 University Plaza
Suite 505
Hackensack, NJ 07601
201-820-2008
www.wwstr.com
BF Borgers CPA PC
5400 West Cedar Avenue
Lakewood, CO 80226
Lucosky Brookman LLPOTCQX Sponsor
101 Wood Avenue South
5th Floor
Woodbridge, NJ 08830
Ron Both, CMA
Email Contact
T: 949-432-7566

Investor Contact Information

Company

Juan Manuel Piñeiro Dagnery
juan@conversionlabs.com
T: (866) 351-5907

Investor Relations

Ron Both, CMA
Email Contact
T: 949-432-7566

Transfer Agent

Worldwide Stock Transfer, LLC
One University Plaza, Suite 505
Hackensack, NJ 07601